Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Colorcon Expands Excipients Business | Contract Pharma

What are you searching for?

Sign in
Breaking News

Colorcon Expands Excipients Business

To build starch manufacturing plant near Amsterdam

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Colorcon has unveiled plans to build a new starch manufacturing plant close to Amsterdam in The Netherlands. By 2022, this new facility is planned to double the existing manufacturing capacity for Starch 1500, Pregelatinized Maize Starch, supporting the continued growth of Colorcon’s excipient business across the world.
 
Strategically located in the heart of Europe and close to the major port of Rotterdam, the site will produce GMP starch products for the pharmaceutical and nutritional markets served by Colorcon in the EMEA region.
 
“The location has been chosen to bring manufacturing closer to our customer base in Europe,” said Nathan Evans, operations project manager – Netherlands, Colorcon. “The plant will provide a secure second source of supply with the same quality, consistency and equivalency to the product manufactured in our existing facility in Indianapolis, IN. The new facility will enable Colorcon to take advantage of new advances in process control and automation to manufacture a product that has over 40 years of history in use across the pharmaceutical industry.”
 
Martti Hedman, chief executive officer, Colorcon, said, “By investing ahead of demand, the facility is also an important step in securing the supply chain for our customers and enhances Colorcon’s business continuity plan as the demand for Starch 1500 continues to grow.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics